Leaderboard

En | De
Sie sind hier: Neurologie » Multiple Sklerose 19. März 2026
Suchen
medline.ch
Multiple Sklerose
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Alzheimer
Epilepsie
Infektionen
Kopfschmerzen
Multiple Sklerose
Neoplasie
Neuromuskuläre Erkrankungen
Parkinson
Zerebrovaskuläre Erkrankungen
ZNS Trauma
Anderes
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2179  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 43563  
   
Neutropenia after ocrelizumab treatment in patients with multiple sclerosis: A single-centre case series and systematic review of literature.
Mult Scler Relat Disord
Silva JA, Delgado S, Santos M, Leitão L.
PMID: 41850122 [PubMed - as supplied by publisher]


Effect of Dalfampridine on cognition, gait and fatigue in patients with multiple sclerosis: a randomized placebo-controlled study.
Mult Scler Relat Disord
Abdeldayem MME, Abdelnasser A, Khalil SH, Hamid E, Abousteit AM, Abushady EM, Shalash A.
PMID: 41850121 [PubMed - as supplied by publisher]


A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis.
Eur J Epidemiol
Verweij S, Bijlsma MJ, Rengerink KO, Hillert J, Forsberg L, Mouresan EF, Glaser A, Fox RJ, Hak E, Mol P.
PMID: 41849089 [PubMed - as supplied by publisher]


Characterisation of Ocular Manifestations in Patients with Multiple Sclerosis in Colombia: A Multicentric Study.
Neuroophthalmology
Manrique-Samer A, Cifuentes-González C, Álvarez-Martínez JV, Rojas-Carabali W, Cortes-Albornoz MC, Vélez Van-Meerbeke A, Ortiz-Salas PA, Casallas-Vanegas A, Guío-Sánchez CM, Cardona-López J, Mejía-Salgado G, de-la-Torre A.
PMID: 41847272 [PubMed]


Targeting Epstein-Barr virus (EBV) for treatment of multiple sclerosis.
Mult Scler Relat Disord
Soldan SS, Messick TE, Lieberman PM.
PMID: 41846093 [PubMed - as supplied by publisher]


Treatment-free remission in MS: long-term disease control with cladribine tablets.
J Neurol
Wiendl H, Gold R, Pul R, Ernst M, Kowarik MC, Klehmet J, Siglienti I, Hübschen M, Wagner T, Knaup J, Kleinschnitz C.
PMID: 41844910 [PubMed - indexed for MEDLINE]


Cognitive Ability in Pediatric-Onset Multiple Sclerosis: A Case Series.
Pediatr Neurol
Ballarà Petitbò M, Orduña BE, Oyaga de Frutos E, Muñiz IS, Melero Llorente J, Duat Rodríguez A, Cantarín Extremera V.
PMID: 41844096 [PubMed - as supplied by publisher]


Frequency of AQP4 and MOG Antibodies in Patients With Optic Neuritis Fulfilling Minimal New Multiple Sclerosis MRI Criteria.
Neurology
Deschamps R, Papeix C, Demortiere S, Lardeux P, Boudot De La Motte M, Pique J, Boutiere C, Duron L, Chaugne E, Maarouf A, Froment Tilikete C, Marignier R, Audoin B.
PMID: 41843863 [PubMed - indexed for MEDLINE]


The Relationship Between Subjective and Objective Fatigue Assessment Approaches in Multiple Sclerosis: A Meta-Analysis.
Neuropsychol Rev
Fleischmann HH, Derusha AE, Kiselica AM, Correia S, Sweet LH.
PMID: 41843295 [PubMed - as supplied by publisher]


Single-Cell and Mendelian Randomization Analyses Identify Key Genes Common to COVID-19 and Multiple Sclerosis.
Viral Immunol
Chen S, Ruan J, Cheng S, Zheng H, Chang T, Bao G, Zhu Z, Li X, Zhao W, Zheng K.
PMID: 41841545 [PubMed - as supplied by publisher]


Linking movement-related beta oscillations to cortical excitability, structural damage, and fatigue in multiple sclerosis.
Brain Commun
Tatti E, Benelli A, Cinti A, Cortese R, Serbina A, Kulapurathazhe AJ, Saed S, Luchetti L, Cudeiro J, Zhang J, de Mauro A, Neri F, Stromillo ML, Baldi TL, d'Aurizio N, Battaglini M, Plantone D, Righi D, Massucco E, Giannotta A, Lomi F, Scoccia A, Lai G, Ulivelli M, Ghilardi MF, De Stefano N, Rossi S.
PMID: 41835133 [PubMed]


Repetitive transcranial magnetic stimulation to alleviate fatigue in multiple sclerosis-study protocol for a randomized sham-controlled double-blinded clinical trial.
Front Neurol
Nygaard S, Madsen MAJ, Wiggermann V, Cabras C, Christiansen L, Svatkova A, Lundell H, Højsgaard Chow H, Romme Christensen J, Blinkenberg M, Sellebjerg F, Siebner H.
PMID: 41835064 [PubMed]


Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study.
BMJ Neurol Open
Rasmussen TH, Schikora-Rustad S, Lorentzen ÅR, Tran TT, Øverås MH, Myhr KM, Wergeland S, Aarseth J, Bø L, Berge T, Høgestøl EA, Harbo HF, Tveter AT, Jørgensen KK, Cunen C, Torkildsen Ø, Holmøy T, Celius EG, Vaage JT, Nygaard GO, Lund-Johansen F, König M.
PMID: 41835014 [PubMed]


Prevalence and clinical implications of abnormal autoantibodies in Omani patients with multiple sclerosis: A retrospective cross-sectional study.
Mult Scler Relat Disord
Al-Maskari M, Al-Asmi A, Islam MM, Al-Hidabi R, Elyas M, AlShekaili J, Al-Kindi M, Rashed SS.
PMID: 41833243 [PubMed - as supplied by publisher]


Access and barriers to diagnosis of multiple sclerosis in Iran - A clinician survey.
Mult Scler Relat Disord
Khodadadi S, Bahrami SN, Jahani S, Sahraian MA, Solomon AJ.
PMID: 41832843 [PubMed - as supplied by publisher]


Perceived value of physiotherapy and occupational therapy among people with multiple sclerosis: insights from a qualitative interview study.
Mult Scler Relat Disord
Beckerman H, Coppers JP, Eijssen IC.
PMID: 41832841 [PubMed - as supplied by publisher]


Can Blood Flow Restriction Training Improve Mental Health and Quality of Life in Multiple Sclerosis?
Arch Phys Med Rehabil
Cano-Sánchez J, Aibar-Almazán A, Hita-Contreras F, Castellote-Caballero Y, Carcelén-Fraile MDC.
PMID: 41831773 [PubMed - as supplied by publisher]


Bridging perspectives on comorbidities in multiple sclerosis: A pilot study with individuals with lived experience and healthcare professionals.
Mult Scler Relat Disord
Karim ME, Sage O, Thandi M, Frank HA, Marrie RA, Tremlett H, McKay K, Cox S, Lix L, Zhu F, Yusuf F.
PMID: 41830893 [PubMed - as supplied by publisher]


CHI3L1 Expression in Neutrophils and Plasma of Multiple Sclerosis Patients: Implications for Pathogenesis and a Potential Biomarker.
Int J Mol Sci
Jatczak-Pawlik I, Ewiak-Paszy, Domowicz M, Bielecki B, , Stasio, Jurewicz A.
PMID: 41828412 [PubMed - indexed for MEDLINE]


Impact of the Combination of Epigallocatechin Gallate and Ellagic Acid Supplemented with Ketone Bodies on Energetic Restoration of Mitochondrial Dysfunction and Metabolic Inefficiencies in Patients with Multiple Sclerosis: A Review.
Int J Mol Sci
de la Rubia Ortí JE, Roig-Soriano A, Carrera-Juliá S, Castelló-Guillen A, Machado M, García-Villalba R, Alarcón-Jiménez J, de Bernardo N, Benlloch M.
PMID: 41828397 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 43563    Seite 1 von 2179  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1